News + Filings Transactions
|
FALBERG KATHRYN E
Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/15/2023 | Arcus Biosciences, Inc. | RCUS | Gift | Common Stock | 50.5k | $0.00 | $0 | | 06/15/2023 |
06/15/2023 | Arcus Biosciences, Inc. | RCUS | Grant | Common Stock | 6.8k | $0.00 | $0 | | 06/15/2023 |
06/15/2023 | Arcus Biosciences, Inc. | RCUS | Grant | Stock Option (Right to Buy) | 19.5k | $19.60 | $382.2k | | 06/15/2023 |
05/25/2023 | Trade Desk, Inc. | TTD | Grant | Class A Common Stock | 4.2k | $0.00 | $0 | | 05/25/2023 |
05/25/2023 | Trade Desk, Inc. | TTD | Grant | Class A Common Stock | 799 | $62.52 | $50k | | 05/25/2023 |
05/15/2023 | Nuvation Bio Inc. | NUVB | Grant | Stock Option (Right to Buy) | 366.7k | $1.64 | $601.5k | | 05/15/2023 |
02/06/2023 | Trade Desk, Inc. | TTD | Disposition | Class A Common Stock | 21 | $59.83 | $1.3k | | 02/06/2023 |
12/05/2022 | Nuvation Bio Inc. | NUVB | Purchase | Class A Common Stock | 43k | $1.95 | $84k | By Trust | 11/30/2022 |
12/02/2022 | Nuvation Bio Inc. | NUVB | Purchase | Class A Common Stock | 47k | $1.98 | $93.2k | By Trust | 11/30/2022 |
12/01/2022 | Nuvation Bio Inc. | NUVB | Purchase | Class A Common Stock | 85k | $1.97 | $167.6k | By Trust | 11/30/2022 |
11/30/2022 | Nuvation Bio Inc. | NUVB | Purchase | Class A Common Stock | 75k | $1.85 | $139.1k | By Trust | 11/30/2022 |
06/15/2022 | Tricida, Inc. | TCDA | Grant | Stock Option (right to buy) | 27.2k | $9.87 | $268.5k | | 06/15/2022 |
06/14/2022 | Arcus Biosciences, Inc. | RCUS | Grant | Common Stock | 4.1k | $0.00 | $0 | | 06/14/2022 |
06/14/2022 | Arcus Biosciences, Inc. | RCUS | Grant | Stock Option (Right to Buy) | 16.8k | $20.62 | $346.4k | | 06/14/2022 |
05/26/2022 | Trade Desk, Inc. | TTD | Grant | Class A Common Stock | 267 | $59.83 | $16k | | 05/26/2022 |
05/26/2022 | Trade Desk, Inc. | TTD | Grant | Class A Common Stock | 83 | $59.83 | $5k | | 05/26/2022 |
05/26/2022 | Trade Desk, Inc. | TTD | Grant | Class A Common Stock | 4.2k | $0.00 | $0 | | 05/26/2022 |
05/26/2022 | Trade Desk, Inc. | TTD | Grant | Class A Common Stock | 835 | $59.83 | $50k | | 05/26/2022 |
05/16/2022 | Nuvation Bio Inc. | NUVB | Grant | Stock Option (Right to Buy) | 118.8k | $4.05 | $481.1k | | 05/16/2022 |
05/16/2022 | Nuvation Bio Inc. | NUVB | Grant | Stock Option (Right to Buy) | 140.7k | $4.05 | $569.9k | | 05/16/2022 |
11/19/2021 | Trade Desk, Inc. | TTD | Sale | Class A Common Stock | 80.6k | $108.03 | $8.7M | By Family Trust | 11/19/2021 |
11/19/2021 | Trade Desk, Inc. | TTD | Sale | Class A Common Stock | 47.7k | $108.90 | $5.2M | By Family Trust | 11/19/2021 |
11/19/2021 | Trade Desk, Inc. | TTD | Sale | Class A Common Stock | 21.5k | $109.98 | $2.4M | By Family Trust | 11/19/2021 |
11/19/2021 | Trade Desk, Inc. | TTD | Sale | Class A Common Stock | 250 | $110.44 | $27.6k | By Family Trust | 11/19/2021 |
10/29/2021 | Nuvation Bio Inc. | NUVB | Grant | Stock Option (Right to Buy) | 45.2k | $9.17 | $414.7k | | 10/29/2021 |
06/10/2021 | Tricida, Inc. | TCDA | Grant | Common Stock | 16.4k | $0.00 | $0 | | 06/10/2021 |
06/10/2021 | Tricida, Inc. | TCDA | Grant | Stock Option (right to buy) | 57.2k | $4.92 | $281.6k | | 06/10/2021 |
06/07/2021 | UroGen Pharma Ltd. | URGN | Grant | Stock Option (right to buy) | 10k | $17.98 | $179.8k | | 06/07/2021 |
06/03/2021 | Arcus Biosciences, Inc. | RCUS | Grant | Stock Option (Right to Buy) | 14.1k | $24.79 | $349.5k | | 06/03/2021 |
06/03/2021 | Arcus Biosciences, Inc. | RCUS | Grant | Common Stock | 3k | $0.00 | $0 | | 06/03/2021 |
05/27/2021 | Trade Desk, Inc. | TTD | Grant | Class A Common Stock | 390 | $0.00 | $0 | | 05/27/2021 |
05/27/2021 | Trade Desk, Inc. | TTD | Grant | Class A Common Stock | 78 | $639.65 | $49.9k | | 05/27/2021 |
05/27/2021 | Trade Desk, Inc. | TTD | Grant | Class A Common Stock | 25 | $639.65 | $16k | | 05/27/2021 |
05/27/2021 | Trade Desk, Inc. | TTD | Grant | Class A Common Stock | 7 | $639.65 | $4.5k | | 05/27/2021 |
03/31/2021 | Arcus Biosciences, Inc. | RCUS | Purchase | Common Stock | 20k | $28.35 | $567k | By Trust | 03/31/2021 |
|
|